170 related articles for article (PubMed ID: 16202400)
1. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.
Furno-de Winter A; Broquet C; Haelters JP; Massicot F; Sturtz G; Godfroid JJ
J Lipid Mediat; 1991; 3(3):289-300. PubMed ID: 1773030
[TBL] [Abstract][Full Text] [Related]
3. Isolation and identification of hydroxyl-platelet-activating factor from natural sources.
Tsoupras AB; Antonopoulou S; Baltas G; Samiotaki M; Panayotou G; Kotsifaki H; Mantzavinos Z; Demopoulos CA
Life Sci; 2006 Oct; 79(19):1796-803. PubMed ID: 16860827
[TBL] [Abstract][Full Text] [Related]
4. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids.
Ostermann G; Hofmann B; Kertscher HP; Till U
Thromb Res; 1991 Feb; 61(3):261-9. PubMed ID: 2028445
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
[TBL] [Abstract][Full Text] [Related]
8. [PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Schmidt B; Ostermann G
Pharmazie; 1992 Mar; 47(3):172-4. PubMed ID: 1615020
[TBL] [Abstract][Full Text] [Related]
9. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Ostermann G
Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
Antonopoulou S; Tsoupras A; Baltas G; Kotsifaki H; Mantzavinos Z; Demopoulos CA
Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473
[TBL] [Abstract][Full Text] [Related]
11. [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].
Benveniste J; Tencé M; Varenne P; Bidault J; Boullet C; Polonsky J
C R Seances Acad Sci D; 1979 Nov; 289(14):1037-40. PubMed ID: 121258
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor and lyso-phosphatidylcholines from strawberry.
Calligerou M; Siafaka-Kapadai A; Galanopoulou D; Weintraub ST; Mavri-Vavayanni M
Phytochemistry; 1996 Jan; 41(1):89-92. PubMed ID: 8588879
[TBL] [Abstract][Full Text] [Related]
13. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions.
Furukawa M; Kubo N; Yamashita T
Laryngoscope; 1995 Feb; 105(2):188-91. PubMed ID: 8544602
[TBL] [Abstract][Full Text] [Related]
14. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
Muzia GI; Kulikov VI
Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
[TBL] [Abstract][Full Text] [Related]
15. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
16. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
18. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
19. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria).
Antonopoulou S; Karantonis HC; Nomikos T; Oikonomou A; Fragopoulou E; Pantazidou A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Nov; 142(3):269-82. PubMed ID: 16198133
[TBL] [Abstract][Full Text] [Related]
20. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
Tokumura A; Yoshida J; Maruyama T; Fukuzawa K; Tsukatani H
Thromb Res; 1987 Apr; 46(1):51-63. PubMed ID: 3647677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
